Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial)
Clinical trial NCT06377267 · UNKNOWN
Trial details
- NCT number
- NCT06377267
- Sponsor
- Vall d'Hebron Institute of Oncology
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-06
- Primary completion
- 2024-03-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.